Showing results (101-110 of 1,070) with videos related to

Sort By:
Pageof 107
Therapeutic Advances in Neurological Disorders|November 3, 2025
Botulinum toxin as a potential adjunct therapy in stiff person syndrome spectrum disordersSamantha N Roman, Jacqueline L Koshorek, Elena R Taylor, et al.
Therapeutic Advances in Neurological Disorders|November 3, 2025
Open-label study of efgartigimod in seronegative myasthenia gravisMohamed Khateb, Ajith Sivadasan, Carolina Barnett-Tapia, et al.
Therapeutic Advances in Neurological Disorders|October 1, 2025
Improving quality of life in rare diseases using disease-specific, multidisciplinary online interventions on the example of rare X-linked adrenoleukodystrophy: a randomized-controlled trialLisa Schäfer, Astrid Unterlauft, Brit Froebrich-Andreß, et al.
Therapeutic Advances in Neurological Disorders|July 3, 2025
Silent protocol modifications in multiple sclerosis clinical trials: a registry-based cross-sectional studyAlejandro Rivero-de-Aguilar, Mónica Pérez-Ríos, Joseph S Ross, et al.
Therapeutic Advances in Neurological Disorders|June 23, 2025
Insights into retention and safety/tolerability of apomorphine sublingual film in patients with Parkinson's disease and OFF episodes: post hoc analyses of a phase III, open-label studyJan Kassubek, Diego Santos Garcia, Wolfgang H Jost, et al.
Therapeutic Advances in Neurological Disorders|December 15, 2025
Efficacy and safety of patisiran for the treatment of acquired amyloid polyneuropathy in domino liver transplant recipientsVelina Nedkova-Hristova, Laura Donadeu, Carmen Baliellas, et al.
Therapeutic Advances in Neurological Disorders|April 28, 2025
Predictors of acute symptomatic seizure in cerebral venous thrombosis patients-a multicenter cohort studyNaaem Simaan, Jeremy Molad, Hen Hallevi, et al.
Therapeutic Advances in Neurological Disorders|September 19, 2025
Twenty years of natalizumab in multiple sclerosis: lessons learned and future outlookLuisa Klotz, Thomas Berger, Wallace J Brownlee, et al.
Therapeutic Advances in Neurological Disorders|September 19, 2025
Approaches for treating cardiovascular symptoms in Parkinson's diseaseWolfgang H Jost, Jiri Koschel
Therapeutic Advances in Neurological Disorders|October 10, 2025
Optimal 24-h NIHSS threshold of ⩽9 predicts 90-day outcomes after posterior circulation thrombectomy: ANGEL-ACT Registry InsightsYiming Deng, Ligang Song, Hanlin Chen, et al.
Pageof 107